The effects of ejaculation on serum prostate specific antigen

Area of Science:

• Urology
• Oncology
• Andrology

Background:

• Prostate specific antigen (PSA) is a key biomarker for prostate cancer diagnosis and monitoring.
• Benign prostatic hyperplasia (BPH) is a common condition in aging men, often accompanied by lower urinary tract symptoms.
• The impact of ejaculation on PSA levels has been a subject of clinical interest, particularly for men with an active sexual life.

Purpose of the Study:

• To evaluate the correlation between ejaculation and serum PSA levels in men diagnosed with symptomatic benign prostatic hyperplasia and an active sexual life.
• To determine if sexual activity influences PSA measurements, potentially affecting prostate cancer screening or monitoring.
• To clarify the physiological relationship between ejaculation and PSA in the context of BPH.

Main Methods:

• A cohort of 40 men aged 50-60 with symptomatic BPH and active sexual lives underwent serum PSA testing.
• PSA levels were measured before ejaculation and at 1 and 7 days post-ejaculation.
• Results were compared to a control group of 10 asymptomatic men within the same age range.

Main Results:

• No statistically significant differences were observed in PSA levels before and after ejaculation within the BPH group.
• PSA levels did not differ significantly between the BPH group and the asymptomatic control group.
• These findings indicate no discernible physiological relationship between ejaculation and PSA levels in this study population.

Conclusions:

• Sexual activity, including ejaculation, does not appear to significantly alter PSA levels in men with symptomatic BPH.
• The study concludes that PSA testing remains a reliable tool for prostate cancer screening in sexually active men.
• These results support current clinical guidelines regarding PSA screening protocols in the presence of regular sexual activity.